Bionano announces china nmpa approval for dna extraction and labeling products for ivd use in hematologic malignancies

San diego, feb. 22, 2023 (globe newswire) -- bionano genomics, inc. (bngo) today announced that its chinese original equipment manufacturing (oem) partner, beijing genome precision technology (bgpt), a comprehensive molecular diagnostics company, has obtained reagent class i registrations from china's national medical products administration (nmpa) for bionano's dna extraction kit and labeling products.
BNGO Ratings Summary
BNGO Quant Ranking